Aerosol influenza transmission risk contours: a study of humid tropics versus winter temperate zone.
BACKGROUND
In recent years, much attention has been given to the spread of influenza around the world. With the continuing human outbreak of H5N1 beginning in 2003 and the H1N1 pandemic in 2009, focus on influenza and other respiratory viruses has been increased. It has been accepted for decades that international travel via jet aircraft is a major vector for global spread of influenza, and epidemiological differences between tropical and temperate regions observed. Thus we wanted to study how indoor environmental conditions (enclosed locations) in the tropics and winter temperate zones contribute to the aerosol spread of influenza by travelers. To this end, a survey consisting of 632 readings of temperature (T) versus relative humidity (RH) in 389 different enclosed locations air travelers are likely to visit in 8 tropical nations were compared to 102 such readings in 2 Australian cities, including ground transport, hotels, shops, offices and other publicly accessible locations, along with 586 time course readings from aircraft.


RESULTS
An influenza transmission risk contour map was developed for T versus RH. Empirical equations were created for estimating: 1. risk relative to temperature and RH, and 2. time parameterized influenza transmission risk. Using the transmission risk contours and equations, transmission risk for each country's locations was compared with influenza reports from the countries. Higher risk enclosed locations in the tropics included new automobile transport, luxury buses, luxury hotels, and bank branches. Most temperate locations were high risk.


CONCLUSIONS
Environmental control is recommended for public health mitigation focused on higher risk enclosed locations. Public health can make use of the methods developed to track potential vulnerability to aerosol influenza. The methods presented can also be used in influenza modeling. Accounting for differential aerosol transmission using T and RH can potentially explain anomalies of influenza epidemiology in addition to seasonality in temperate climates.
Hanley
Brian P
BP
Butterfly Biosciences, Davis, CA 95616, USA. brian.hanley@ieee.org
Borup
Birthe
B
D000336:Aerosols / Q000032:analysis*; D000391:Air Microbiology; D006801:Humans; D006813:Humidity; D007251:Influenza, Human / Q000635:transmission* / Q000821:virology; D012621:Seasons; D013696:Temperature; D014195:Travel; D014329:Tropical Climate
D000336:Aerosols
J Hyg (Lond). 1961 Dec;59:479-86
13904777
Arch Pharm Res. 2002 Dec;25(6):770-80
12510824
Virol J. 2009 Aug 11;6:121
19671177
J R Soc Interface. 2009 Dec 6;6 Suppl 6:S747-55
19740921
Am J Clin Nutr. 1991 Nov;54(5):890-5
1951162
Emerg Infect Dis. 2006 Nov;12(11):1657-62
17283614
Theor Biol Med Model. 2009 Jun 29;6:11
19563624
Antonie Van Leeuwenhoek. 1962;28:221-33
13953681
Arch Intern Med. 2009 Feb 23;169(4):384-90
19237723
BMJ. 2008 Jan 12;336(7635):77-80
18042961
J R Soc Interface. 2009 Dec 6;6 Suppl 6:S783-90
19773292
J Virol Methods. 2008 Oct;153(1):74-7
18598719
J Virol. 2008 Jun;82(11):5650-2
18367530
Lancet Infect Dis. 2007 Apr;7(4):257-65
17376383
Am J Epidemiol. 1979 Jul;110(1):1-6
463858
Nature. 1960 Oct 29;188:430-1
13713229
Nature. 2004 May 13;429(6988):180-4
15141212
Nature. 2005 Nov 17;438(7066):355-9
16292310
Public Health Rep. 2008 Jan-Feb;123(1):52-60
18348480
Arch Virol. 1976;51(4):263-73
987765
Am J Respir Crit Care Med. 2004 Mar 1;169(5):604-9
14656754
J R Soc Interface. 2009 Dec 6;6 Suppl 6:S703-14
19812073
Infect Immun. 1996 Apr;64(4):1100-9
8606065
Theor Biol Med Model. 2006 Aug 23;3:32
16928271
Chest. 2001 Oct;120(4):1377-89
11591584
J Hosp Infect. 2006 Oct;64(2):100-14
16916564
Vaccine. 1999 Jul 30;17 Suppl 1:S3-10
10471173
Epidemiol Infect. 2006 Dec;134(6):1129-40
16959053
Emerg Infect Dis. 2004 Feb;10(2):195-200
15030682
J Gen Physiol. 1997 Sep;110(3):283-96
9276754
Emerg Infect Dis. 2007 Jan;13(1):173-4; author reply 174-5
17370541
Ann N Y Acad Sci. 1980;353:147-56
6261640
Emerg Infect Dis. 2009 Oct;15(10):1578-81
19861048
PLoS One. 2008 Jul 16;3(7):e2691
18628983
Environ Sci Technol. 2008 Jun 1;42(11):3938-43
18589948
PLoS Pathog. 2007 Oct 19;3(10):1470-6
17953482
Virol J. 2008 Feb 25;5:29
18298852
PLoS Med. 2006 Apr;3(4):e89
16509764
J Infect Dis. 2009 Mar 15;199(6):858-65
19434931
Fundam Appl Toxicol. 1988 Jul;11(1):169-80
3209012
PLoS Med. 2008 Mar 25;5(3):e74
18366252
Infect Dis Clin North Am. 2004 Mar;18(1):1-15
15081500